Breaking News on Global Pharmaceutical Technology & Manufacturing

Capsugel and Bend: 'Marriage made in heaven' as first tech transferred

31-Oct-2013 - The acquisition of Bend Research by Capsugel may be “a marriage made in heaven” for customers, the firms say, as the first drug delivery tech is transferred.

UPDATE - Dispatches from CPhI

Capsugel's purchase of Bend will strengthen partnership, says Dow

28-Oct-2013 - Dow says the acquisition of partner Bend Research is “good news” and will strengthen its developments in solving solubility and bioavailability issues in drug formulation.

dispatches from CPhI

Risk-based supply chain management means more audits for excipient firms

28-Oct-2013 - Regulatory pressure for risk-based supply chain management is increasing excipient suppliers’ audit burden according to the team preparing to launch the 'excipact' certification scheme as an independent association.

Nordic partners Enteris; Licenses bioavailability boosting platform

08-Oct-2013 - Enteris has secured its first partnership to develop metabolic peptides for Nordic Bioscience using an oral delivery platform it says offers unparalleled bioavailability.

Excipients Boost Efficacy in Oral Delivery Platform, says Enteris

06-Aug-2013 - Enteris has acquired an oral drug delivery platform from Unigene Laboratories and says the excipients used can increase solubility and absorption for both peptides and small molecules.

News in brief

Catalent Completes Chinese Softgel Acquisition

30-Jul-2013 - Catalent has completed the purchase of a Chinese softgel firm following regulatory approval.

New Particle Tech May Let Formulators Cut Out Costly Lactose says Pulmatrix

24-Jul-2013 - Dry powder inhaler firms may soon be able to eliminate lactose from formulations if a new high dispersibility particle production platform is successful in trials.

Catalent Combines Core Drug Delivery Services Into New Unit

09-Jul-2013 - Increased challenges in drug delivery have led to Catalent integrating its technologies and services in order to create a new business unit.


'Critical' Compliance for Biologics with Nasal and Long Acting Techs

26-Jun-2013 - Critical Pharmaceuticals says its protein and peptide delivery technologies offer long acting injectables and greater compliance, saving money and easing patient administration.

Capsugel Launches Lipidex Encapsulating Platform from New Dosage Form Unit

17-Jun-2013 - The latest technology platform from Capsugel's four-month old DFS Unit offers greater bioavailabilty and stability in oral dose formulation, says the company.

Metrics Latest Company to Offer Extrusion and Speronization Tech

18-Apr-2013 - Following its acquisition by Mayne Pharma, Metrics says it is to offer proprietary pellet form technology for advanced drug release and to increase bioavailability.


Battling Bioavailability? Find Your Solubility Solution at BAC 2013!

18-Mar-2013 - Drug solubility science, technology and solutions will take centre stage at “The Bioavailability Challenge” a free to attend online event is hosting on Wednesday, March 20. 

BASF says Bend Accord Targets Different Chemistries than Dow deal

25-Feb-2013 - Bend Research has partnered with its second chemistry major in six months, teaming up with BASF to develop bioavailability-boosting excipients.

DSM says generics-focused partnering will drive pharma growth

20-Feb-2013 - Royal DSM expects its pharma unit to perform better in 2013 driven by a generics and end-of-lifecycle drug-focused partnership strategy. 

Dow Signs Up Cambrex for Bioavailability Partnership

19-Feb-2013 - Dow has contracted Cambrex to make its solubility enhancing polymer HPMCAS, adding manufacturing clout to its bioavailability-focused collaboration with Bend Research.


Aesica and EmulTech Claim Micro-Encapsulation can Revive Formulation Projects

18-Feb-2013 - Aesica and EmulTech claim a new sterile formulation technology could help drugmakers resurrect abandoned projects and extend the lifespan of marketed medicines.

EpiVax says Novozymes Collaboration has $3bn Potential

13-Feb-2013 - EpiVax says combining its immune 'off switch’ drugs with Novozymes’ half-life boosting Albufuse platform could deliver a $3bn (€2.2bn) section of the autoimmune disease market.

Swedish Body Certifies Bend Research for EU GMP Compliance

11-Feb-2013 - Bend Research says collaboration between the Swedish MPA and the US FDA was the reasoning in pursuing GMP from the European body.

Bioavailability drives Patheon and Catalent investments

04-Feb-2013 - Patheon says expanding its UK facility is necessary in offering its Solupath services to a European and Asian market.

Solvias buys Confarma for EU pharma quality control capacity

04-Feb-2013 - Solvias has bought quality control services firm Confarma, expanding its analytical offering and adding capacity in several EU markets.

Scinopharm starts developing own drugs with eye on API customers

30-Jan-2013 - Taiwanese API maker Scinopharm has taken a first step towards developing its own drug portfolio in partnership with delivery tech firm Foresee Pharmaceuticals.

Find esophageal transit failure hard to swallow? Fuisz says new pill design can help

24-Jan-2013 - Fuisz Pharma says a new tablet design will be of interest to pharma formulators who find esophageal transit failures hard to swallow.

Cost of dissolution testing for levothyroxine a small price to pay for quality says MHRA

23-Jan-2013 - The cost of proposed new tests designed to ensure levothyroxine tablet quality is a small price to pay for manufacturers to ensure patient safety says the UK MHRA.

Bioavailability to drive drug delivery deals in 2013 says analyst

15-Jan-2013 - Demand for improved bioavailability solutions will drive drug delivery dealmaking in 2013 according to a pharmaceutical industry expert.

IDIFarma OKed to make commercial batches of high-potency drugs

14-Jan-2013 - IDIFarma has been cleared to make commercial batches of high potency tablets and hopes the new capability will attract developers of niche drugs and large CMOs. 

Key Industry Events


Access all events listing

Our events, Shows & Conferences...